CCAAT/enhancer binding protein epsilon (C/EBP⑀) is essential for terminal granulocytic differentiation. Its expression begins at the transition between the proliferative and non-proliferative compartments of myelopoiesis. We studied the effect of targeted disruption of the C/EBP⑀ gene on murine myeloid proliferation and apoptosis. Bone marrow cellularity of C/EBP⑀ −/− and wild-type mice was 95% and 65%, respectively. The C/EBP⑀ −/− mice had an expansion in the number of their CFU-GM/femur. The number of myeloid committed progenitor cells in the peripheral blood and the spleen of these mice was also increased. Bromodeoxyuridine (BrDU) pulse labeling studies demonstrated that the fraction of actively proliferating cells was two-fold higher in the bone marrow of C/EBP⑀ −/− mice. However, the number of myeloid colonies arising from purified Sca-1+/lin− early hematopoietic progenitor cells and from bone marrow mononuclear cells grown in different cytokine combinations was not significantly different between wild-type and knock-out mice. Also, long-term marrow growth, and CFU were not different between the wild-type and C/EBP⑀ −/− mice. The sensitivity to induction of apoptosis in the committed progenitor cell compartment after either withdrawal of growth factor or brief exposure to etoposide was normal. However, Gr-1 antigen-positive C/EBP⑀ −/− granulocytic cells showed an increased rate of apoptosis in comparison to their wild-type counterparts. In summary, the myeloid compartment appears to be expanded in mice lacking C/EBP⑀. However, this is not the consequence of an intrinsic myeloproliferation but due to an indirect, possibly cytokine-mediated stimulation of myelopoiesis in vivo. C/EBP⑀ may have a role in the inhibition of apoptosis in maturing granulocytic cells. Leukemia (2001) 15, 103-111.
Introduction
Transcription factor CCAAT enhancer binding protein epsilon (C/EBP⑀) plays a crucial role in terminal granulocytic differentiation. 1, 2 Mice with a targeted disruption of the C/EBP⑀ locus lack mature granulocytes. The most differentiated C/EBP⑀ −/− granulocytic cells are dysplastic and not fully functional. They have a significantly reduced capacity to produce superoxide and an impaired migratory function. 1 Expression of C/EBP⑀ is nearly limited to the granulocytic pathway, levels of the protein become prominent at the promyelocyte stage [3] [4] [5] and continue to be expressed in the most mature stages of granulocytopoiesis. In mature neutrophils, C/EBP⑀ is involved in the regulation of genes important for antimicrobial defense such as the cathelin-related protein (murine homolog of hCAP18) and lactoferrin. [6] [7] [8] Due to these defects in host defense, the animals die at the age of 3-5 months of gram-negative sepsis. Upregulation of C/EBP⑀ in terminal granulocytic differentiation is associated with a loss of proliferation. Interestingly, C/EBP␣ is known to be crucial for the loss of proliferation in differentiating hepatocytes and the upregulation of the cyclindependent kinase inhibitor, p21/waf1. 9, 10 The overexpression of factors associated with proliferation, such as c-myc, antaCorrespondence: HP Koeffler; Fax: 310-423-3030 Received 27 January 2000; accepted 13 May 2000 gonizes myeloid differentiation. C/EBP⑀ restores the ability of 32D cells, which overexpress c-myc, to differentiate. 11 Hence, C/EBP⑀ may play an active role in the pathways integrating proliferation and differentiation in granulocytopoiesis. Alternatively, C/EBP⑀ induces the expression of target genes such as lactoferrin in mature granulocytes which may be involved in the negative (feedback) regulation of myelopoiesis. 12, 13 The bone marrow morphology of C/EBP⑀ −/− mice suggested the coexistence of increased proliferation and apoptosis, with nearly 100% cellularity on biopsy specimen of the marrow and prominent pseudo-Gaucher cells throughhout the marrow. We, therefore, investigated whether myeloid cells in C/EBP⑀ −/− mice show abnormalities in their proliferative behavior in vivo and in vitro as well as in their response to apoptotic stimuli.
Materials and methods

Animals
Homozygous C/EBP⑀ −/− mice were established in a mixed 129/SvEv × NIH Black Swiss background by Yamanaka et al. 1 C/EBP⑀ −/− and control C/EBP⑀ +/+ 129/SvEv × NIH Black Swiss mice were kindly provided by Dr K Xanthopoulos and bred under sterile conditions in the animal housing facility at Cedars-Sinai Medical Center. For all experiments, age matched littermates were used. Mice were sacrificed by cervical neck dislocation. Bone marrow was flushed from isolated femurs and tibiae with IMDM + 20% FBS using a No. 26 gauge needle into plastic culture dishes. Cells were incubated for 1 h at 37°C in an humidified atmoshere with 5% CO 2 in air. Non-adherent cells were either used directly for colonyforming assays or after Ficoll-Hypaque density gradient centrifugation to generate mononuclear cells. Neutrophils were harvested 12 h after intraperitoneal injection with 2 ml 4% thioglycollate by peritoneal lavage with sterile PBS.
Cell cycle analysis
Mononuclear bone marrow cells were prepared and resuspended in 1 ml PBS. Two ml ice-cold methanol was added dropwise for fixation. Prior to cell cycle analysis, cells were treated with RNAse H and resuspended in PBS containing 5 g/ml propidiumiodide.
BrdU incorporation
Mononuclear bone marrow cells of C/EBP⑀ −/− mice and controls were incubated in IMDM + 20% FBS supplemented with 10 M bromodeoxyuridine for 1 h. Cells were washed twice in cold PBS and resuspended in 100 l PBS. Cells were added dropwise to 5 ml ice-cold 70% ethanol and incubated for 30 min. After fixation, cells were incubated in 1 ml of 2 N HCl/Triton X-100 for 30 min followed by neutralization in 1 
Cell sorting
A FITC-conjugated antibody to Sca1, and phycoerythrin-conjugated antibodies to Gr-1, CD11b, B220 and CD5 were purchased from Pharmingen, San Diego, CA,USA. 5 × 10 7 bone marrow mononuclear cells were isolated by Ficoll-Hypaque density gradient centrifugation. These cells were preincubated with FcBlock (Pharmingen) for 15 min on ice. Titrated amounts of Sca-1, Gr-1, CD11b, B220, CD5 antibodies were added and cells were incubated for an additional 15 min on ice. Then, cells were washed twice in cold PBS and resuspended in RPMI + 10% FBS for cell sorting. Sca+(FITC+)/lin-(phycoerythrin−) cells were sorted under sterile conditions using a FACS Star cell sorter into sterile 2 ml Falcon tubes prefilled with 1 ml warm IMDM plus 10% FBS.
Colony-forming assay
Bone marrow was prepared as described above. A total of 10 4 bone marrow cells (either non-fractionated, non-adherent cells or mononuclear cells) or 2 × 10 3 Sca1+/lin− sorted cells were added 1:10 to 2 ml Methocult M3234 (Stem Cell Technology, Vancouver, Canada). The final concentrations of methylcellulose and the supplements were: 1% methycellulose, 15% FBS, 1% BSA, 10 g/ml bovine pancreatic insulin, 200 g/ml iron saturated transferrin, 10 −4 m 2-mercaptoethanol, and 2 mm l-glutamine. Recombinant cytokines were added as indicated in individual experiments. Each sample was plated in triplicate in 0.5 ml aliquots into a 24-well plate. Culture plates were incubated at 37°C in an humidified atmosphere with 5% CO 2 in air. Colonies were counted on day 10. Numbers are given as means ± standard deviations.
Long-term bone marrow culture
The murine fibroblast cell line M2-10B4 was propagated in RPMI 1640 + 10% FBS. Confluent adherent cells were trypsinized, irradiated with 70 Gy and seeded at 5 × 10 4 /cm 2 into 25 cm 2 Falcon culture flasks. Long-term cultures were initiated with 8 × 10 6 bone marrow mononuclear cells in 8 ml IMDM + 10% FBS, 10% pretested horse serum, 2 mm lglutamine and 10 −4 m hydrocortisone. The cultures were incubated at 33°C with 5% CO 2 in air. Fifty percent of the medium was carefully removed once a week and replaced with fresh long-term culture medium. Colony assays were performed with cells in the supernatant.
Annexin V staining
Granulocytes/monocytes isolated by peritoneal lavage at 12 h after intraperitoneal injection of 4% thioglycollate were stained immediately with a phycoerythrin-conjugated antibody to the granulocytic differentiation antigen Gr-1, and a FITC-conjugated antibody to Annexin V and 7-AAD (Viaprobe (Pharmingen)). The percentage of apoptotic (annexin Vpositive/7-AAD-negative) and dead (annexin V-positive/7-AAD-positive) cells was measured by FACS analysis. The percentage was determined in the Gr-1-positive population.
Cytokine ELISA (murine TNF␣, GM-CSF)
Murine TNF and GM-CSF were measured by two-antibody ELISA using biotin-streptavidin-peroxidase detection. Polystyrene plates (Maxisorb; Nunc, Rochester, NY, USA) were coated with capture antibody in PBS overnight at 25°C. The plates were washed four times with 50 nm Tris, 0.2% Tween 20, pH 7.0-7.5 and then blocked for 90 min at 25°C with assay buffer (PBS containing 4% BSA (Sigma, St Louis, MO, USA) and 0.01% Thimerosal, pH 7.2-7.4). The plates were washed four times, and 50 l assay buffer was added to each well along with 50 l of sample or standard prepared in assay buffer and incubated at 37°C for 2 h. The plates were washed four times and 100 l of biotinylated detecting antibody in assay buffer was added and incubated at 25°C for 30 min. After washing the plate four times, streptavidin-peroxidase polymer in casein buffer (RDI) was added and incubated at 25°C for 30 min. The plate was washed four times and 100 l commercially available substrate (TMB, DAKO, Carpinteria, CA, USA) was added and incubated at 25°C for approximately 10-30 min. The reaction was stopped with 100 l 2 n HCl and the A 450 (minus A 650) was read on a microplate reader (Molecular Dynamics, Piscataway, NJ, USA). A curve was fitted to the standards using a computer program (Soft Pro, Molecular Dynamics) and the cytokine concentration in each sample was calculated from the standard curve equation. The ranges of the assays were 15.6 pg/ml to 1000 pg/ml for TNF and 12.5 pg/ml to 800 pg/ml for GM-CSF.
Statistics
Descriptive statistics (mean, standard deviation (s.d.)) and statistical comparisons between groups with a two-tailed Student's t-test were performed using the Instat 2 software (Graphpad, San Diego, CA, USA). Cell cycle data were evaluated with a univariate analysis considering age and group (C/EBP⑀ −/− vs C/EBP⑀ +/+) as influencing factors.
Results
Proliferation
The visual estimate of bone marrow cellularity of C/EBP⑀ −/− and wild-type mice was 95% and 65%, respectively. The composition of myeloid bone marrow cells differed between C/EBP⑀ −/− and wild-type mice. C/EBP⑀ −/− mice had a left shift with an increased percentage of myeloblasts (1.5% vs 1% in normals), promyelocytes (2% vs 1% ), myelocytes (15% vs 8%), metamyelocytes (31% vs 9%) and band forms ( type and knock-out mice with age. The myeloid:erythroid (M:E) ratio increased from 1:1.5 at the age of 3 days to 3:1 at the age of 3 months in the wild-type and up to 4:1-5:1 in the knock-out mice. The percentage of mature Gr-1 positive cells in the bone marrow was 15-20% lower in the knock-out animals than in the wild-type animals ( Table 1) . The mean white cell count in the peripheral blood of young C/EBP⑀ −/− mice (3 days to 3 weeks) was 1.7-fold higher than age-matched controls; the mean WBC of older knock-out animals (4 weeks to 4 months) was 2.4-fold higher than wild-type controls (Table 1) . This increase was due to a higher absolute number of granulocytic lineage cells in the peripheral blood. The Table 1 Comparison between wild-type and C/EBP⑀ −/− age-dependent cell cycle distribution and immunophenotype of total nucleated bone marrow cells and peripheral blood white blood cell counts 
Cell cycle analysis was performed on methanol-fixed, propidium iodide stained total nucleated bone marrow cells from wild-type and C/EBP⑀ −/− mice (n = 3). S-phase fraction in the bone marrow, percentage of Gr-1-positive cells in the bone marrow, and peripheral white blood cell counts of knock-out animals are in bold text. Numbers given are the mean ± s.d.
Leukemia mean percentage of granulocytes was 12% in wild-type animals vs 24-39% dysplastic granulocytic cells in knock-out animals.
Cell cycle analyses of bone marrow cells from C/EBP⑀ −/− and wild-type mice were performed. To reflect their in vivo proliferative status, bone marrow cells were fixed in methanol immediately after their harvest. Figure 2a shows the cell cycle distribution of marrow cells from C/EBP⑀ −/− and wild-type mice, both 3 weeks old. Furthermore, Table 1 summarizes a comparison of cell cycle data of marrow cells from wild-type and C/EBP⑀ −/− bone marrows from mice of different ages (n = 3 for each group). All samples were also stained with anti- bodies directed against the granulocytic antigen Gr-1 and the myeloid marker CD11b to estimate the number of myeloid cells and their degree of maturity. In both wild-type and C/EBP⑀ −/− mice, the percentage of cells in S phase decreased with age along with an increase of myeloid cells. This result represents the age-dependent decrease of erythroid precursor cells in wild-type and knock-out bone marrow and their decreasing contribution to S-phase. However, consistent with our morphological analysis, we found an increased number of hematopoietic cells in S-phase in the knock-out mice at all ages that were examined. Knock-out animals of all ages showed a 50-100% increase of cells in S-phase compared to age-matched controls. These results were confirmed by pulselabeling studies with bromodeoxyuridine (BrDU) which also showed a higher percentage of cells undergoing DNA replication in the C/EBP⑀ −/− mice (Figure 2b ). To exclude an intrinsic proliferative capacity of more mature myeloid cells, we performed a cell cycle analysis of nucleated peripheral blood cells; proliferating cells were not observed (data not shown).
The number of myeloid colonies derived from total nucleated bone marrow cells was 1.5 to two-fold higher in the knock-out as compared to the wild-type mice (Table 2) . Since the total number of nucleated bone marrow cells isolated from a femur of the same size and age mouse was approximately 1.5-fold higher in the knock-out compared to the wild-type mice (2.4 ± 0.38 × 10 6 vs 1.5 ± 0.35 × 10 6 , respectively), reflecting the hypercellular bone marrow, the absolute number of myeloid progenitors was estimated to be two-to three-fold higher in the bone marrow of C/EBP⑀ −/− mice. Interestingly, the number of CFU-GM derived from the peripheral blood and the spleen was also significantly higher in C/EBP⑀ −/− mice, an additional sign of an expanded pool of myeloid progenitors (Table 2 ).
Also, we tested the in vivo response to injections of G-CSF. We administered i.p. 250 g/kg G-CSF/day into three wildtype and three C/EBP⑀ −/− mice for 2 weeks; the dose was increased to 750 g/kg/day for the following 2 weeks. White blood cell counts (WBC) were determined on days 8, 10, 12, 15, 17, 20, 22, 24, 27, 30. (Figure 3 ). As described above, C/EBP⑀ −/− mice had a slightly higher WBC than wild-type mice in their steady state. However, in the experiment Comparison between C/EBP⑀ +/+ and C/EBP⑀ −/− mice: number of total nucleated bone marrow cells isolated from the femur (TNBMC) and summary of myeloid colony growth (CFU-GM, CFU-G, CFU-M) from different cell sources: total nucleated bone marrow cells (TNBM), mononuclear bone marrow cells (MNC-BM), sorted Sca-1 antigen-positive, lineage antigen-negative cells and mononuclear cells isolated from either the peripheral blood (PB-MNC) or spleen.
Figure 3
Peripheral white blood cell counts (WBC) of C/EBP⑀ +/+ and C/EBP⑀ −/− mice (n = 3) before and during injection of human recombinant G-CSF at 250 g/kg for days 1-14 and 750 g/kg for days 15-30. Means and standard deviations are plotted. depicted here, the difference between the groups at baseline did not reach statistical significance. Both wild-type and knock-out mice had an increase in white blood cell counts with G-CSF treatment. After 7 days G-CSF treatment, the C/EBP⑀ −/− cohort showed significantly higher WBC than wild-type animals (P Ͻ 0.01; Figure 3 ). These results are consistent with an increased pool of committed, G-CSF responsive, progenitor cells in C/EBP⑀ −/− mice. At later time points, variation within the cohorts was high and no significant differences were observed.
Suprisingly, we did not observe a significant difference in myeloid colony formation between wild-type and knock-out using bone marrow mononuclear cells after Ficoll-Hypaque density gradient centrifugation for colony-forming assays (Table 2) . A comparison of colony growth in various growth factor combinations including G-CSF, M-CSF, GM-CSF alone or in combination with stem cell factor, IL-3 and IL-6 did not show any significant differences in colony numbers between wild-type and knock-out bone marrow mononuclear cells
Leukemia
Figure 4
Myeloid colony formation of 10 4 C/EBP⑀ +/+ and C/EBP⑀ −/− bone marrow mononuclear (MNC) cells with different cytokine combinations: 100 ng/ml recombinant, murine GM-CSF; 100 ng/ml recombinant human G-CSF; 100 ng/ml recombinant murine M-CSF; 50 ng/ml recombinant murine stem-cell factor; 10 ng/ml interleukin 3; 10 ng/ml interleukin 6.
( Figure 4 ). To better understand the influence of Ficoll separation on myeloid colony growth, we studied the composition of wild-type and C/EBP⑀ −/− bone marrow cells before and after the procedure. Cytospin preparations demonstrated that in wild-type bone marrow, immature myeloid cells were enriched by Ficoll separation since granulocytes and bands were removed: 16 ± 5% residual granulocytes, bands and metamyelocytes after Ficoll vs 49% without Ficoll. Dysplastic C/EBP⑀ −/− metamyelocytes/bands were very inefficiently removed by Ficoll separation. In comparison to a mean of 50% bands and metamyelocytes without Ficoll we counted 47 ± 8% residual dysplastic metamyelocytes and bands after Ficoll. The discrepancy between our results with total bone marrow nucleated cells and bone marrow mononuclear cells was therefore, at least in part, due to a difference in the composition of C/EBP⑀ −/− and wild-type bone marrow cells. Also, no difference was observed in colony numbers between C/EBP⑀ −/− and wild-type mice when sorted Sca1+/lin− early hematopietic stem cells were used in the colony-forming assays (Table 2) .
Leukemia
Cell survival and apoptosis
The composition of bone marrow cells is determined not only by proliferation and differentiation but also by the survival of different myeloid cell populations. We determined the rate of apoptosis in response to apoptotic stimuli and the percentage of apoptotic cells in the mature myeloid compartment.
To study progenitor cell survival, we initiated long-term cultures with bone marrow of wild-type and knock-out mice. The median decline in colony numbers during the first 3 weeks of culture was identical ( Figure 5 ). We also tested the sensitivity of bone marrow cells to exposure to etoposide, a known apoptosis inducing agent. Wild-type and C/EBP⑀ −/− bone marrow cells (10 6 ) were incubated for 4 h in various concentrations of etoposide, washed thoroughly and plated in methylcellulose with SCF, IL-3, IL-6 and GM-CSF. Colony formation was determined on day 10. No difference was found between wild-type and knock-out cells in respect of their sensitivity towards etoposide ( Figure 6 ).
To study the survival of more mature myeloid cells, we collected Gr-1-positive C/EBP⑀ −/− and wild-type cells from the peritoneal cavity 12 h after the i.p. injection of 4% thioglycollate. Immediately after isolation, the percentage of apoptotic and dead cells was determined by triple immunofluorescence staining with Annexin V FITC, 7-AAD and the phycoerythrinconjugated surface marker Gr-1. The samples were immedi-
Figure 5
Parallel decline of C/EBP⑀ +/+ and C/EBP⑀ −/− committed progenitor cells (CFU) in the long-term bone marrow culture (LTC) system. Long-term cultures were initiated with 8 × 10 6 bone marrow mononuclear cells in 8 ml IMDM + 10% FBS, 10% pretested horse serum, L-glutamine and 10 −4 M hydrocortisone. The cultures were incubated at 33°C with 5% CO 2 in air. Fifty percent of the medium was carefully removed once a week and replaced with fresh longterm culture medium. Colony assays were performed with all cells in the supernatant in 1% methylcellulose, 15% FBS, 1% BSA, 10 g/ml bovine pancreatic insulin, 200 g/ml iron saturated transferrin, 10 −4 M 2-mercaptoethanol, 2 mM L-glutamine, 50 ng/ml recombinant murine stem cell factor; 10 ng/ml interleukin 3; 10 ng/ml interleukin 6 as described above. Colony numbers/ml supernatant were calculated. The figure summarizes data from four independent experiments, eg bone marrow samples from four wild-type and four knock-out mice. The natural logarithm of the mean colony number/ml was plotted vs the time after initiation of the LTC. ately analyzed in a FACScan. As described previously, C/EBP⑀ −/− granulocytic cells showed a markedly reduced expression of the Gr-1 antigen. 1 Although the rate of apoptosis is normally high in a population of short-lived mature granulocytes in wild-type mice (here: mean, three mice: 42% ± 7 apoptotic cells), the percentage of apoptotic cells was significantly higher in the Gr-1-positive cell compartment from the C/EBP⑀ −/− mice (mean, three mice: 69% ± 12 apoptotic cells, P Ͻ 0.01) (Figure 7a) . The morphological examination of the cells supported the notion of a very high rate of apoptosis with nuclear condensation and karyorhexis in the population of granulocytic cells in the C/EBP⑀ −/− mice (Figure 7b ).
Cytokine levels
An increased myeloid proliferation may be mediated indirectly by a reactive cytokine cascade. We examined levels of serum GM-CSF and TNF␣ in the serum of six wild-type and 10 C/EBP⑀ −/− mice of different ages (7 days to 4. months). None of the mice had a detectable serum level of GM-CSF (lower detection limit: 12.5 pg/ml). None of the controls showed detectable levels of TNF␣. Only one C/EBP⑀ −/− mouse (age 4. months) had an increased serum TNF␣ level: 51 pg/ml (lower detection limit: 15 pg/ml).
Discussion
Our findings indicate a high turnover in the myeloid cell compartment in C/EBP⑀ −/− mice. An increased proliferation rate is combined with an increased rate of apoptosis of the more mature granulocytic cells. Our in vitro data do not support the notion of an intrinsic myeloproliferation. Purified early hematopoietic progenitor cells from C/EBP⑀ −/− mice produced the
Figure 6
Total bone marrow cells isolated from the femur of C/EBP⑀ +/+ and C/EBP⑀ −/− mice were incubated for 4 h in different concentrations of etoposide, washed thoroughly and plated in methylcellulose with 50 ng/ml murine recombinant stem cell factor, 100 ng/ml interleukin 3, and 10 ng/ml interleukin 6. Myeloid colony growth was scored on day 10. same number of myeloid colonies in the presence of IL-3, IL-6, SCF ± GM-CSF as the wild-type progenitors. Also, no apparent difference in colony size was noted. C/EBP⑀ −/− progenitor cells have the same survival as the wild-type progenitors after either growth factor withdrawal or short-term incubation with etoposide. Furthermore, C/EBP⑀ −/− granulocytic progenitor cells showed a normal proliferative response to G-CSF in vivo and in vitro. This is consistent with the expression of the receptor for G-CSF on granulocytic progenitor cells from C/EBP⑀ −/− cells. 1 Interestingly, we have found an increased absolute number of both nucleated cells and myeloid progenitors in the bone marrow, spleen and the peripheral blood, reflecting an expanded myeloid progenitor cell pool. Since immature myeloid progenitors do not express C/EBP⑀, an intrinsic alteration of cell adhesion molecules and a subsequent redistribution of progenitors is an unlikely cause for this finding. 2 Various possibilities could explain a reactive in vivo expansion of myelopoiesis in C/EBP⑀ −/− mice. One possibility might be stimulation from chronic endotoxin exposure as a consequence of the antimicrobial defect of the neutrophils. 14, 15 We studied the possibility that bacterial infections (LPS) may trigger TNF␣ secretion in C/EBP⑀ −/− monocytes which could lead to increased serum G-CSF and/or GM-CSF levels. 16, 17 Only one (4. month old) out of 10 mice had increased TNF␣ serum levels. None had increased GM-CSF levels. In addition, very young C/EBP⑀ −/− mice raised in a Leukemia germ-free environment did not appear to get sick, but they already had an increased number of proliferating bone marrow cells. Infections appear to be a late complication in the knock-out mice (approximately at 4 months), not the driving force of myeloproliferation.
Granulocyte colony-stimulating factor (G-CSF) is known to be the most important factor for the homeostasis of in vivo granulocytopoiesis. 18 Endogenous G-CSF levels, which have not been studied here, could be increased due to LPSmediated stimulation of G-CSF secretion by monocytes or potentially due to decreased G-CSF plasma clearance, possibly resulting from the absence of mature granulocytes. 19, 20 An interesting speculation is that C/EBP⑀ −/− mice lack an inhibitory factor normally expressed by mature granulocytes. As recently reported, C/EBP⑀ −/− granulocytes lack expression of secondary granule products including lactoferrin because transcriptional expression of these genes requires the transactivation by C/EBP⑀. 5, 6 A provocative series of experiments by Broxmeyer et al [21] [22] [23] [24] showed that lactoferrin was an inhibitory factor for myelopoiesis in vitro and in vivo. Lactoferrin was shown to inhibit myeloid colony-forming cells and suppress GM-CSF and IL-1 production by a subpopulation of monocytes/macrophages. IL-1 can induce GM-CSF expression in fibroblasts. 25, 26 However, GM-CSF serum levels were not increased in C/EBP⑀ −/− mice which conflicts with this speculation.
An alternative possibility relies on the fact that 19 chemo-kines have been reported to inhibit myelopoiesis, 27, 28 including monocyte-chemotactic peptide-1 (MCP-1), macrophage inflammatory protein (MIP)-1 alpha, MIP-related protein 2 (MRP2) and interleukin 8. Some of these have a direct inhibitory effect on the growth of myeloid progenitors. [29] [30] [31] [32] [33] We recently showed that the targeted disruption of C/EBP⑀ also affects monocyte function. 6 MCP and MIP-1 alpha have been implicated as target genes of C/EBP⑀ in monocytes. 34 A reduced or absent expression of these myelosuppressive cytokines or chemokines by C/EBP⑀ −/− monocytes/macrophages could be an additional or alternative mechanism for the enhanced myelopoiesis in C/EBP⑀ −/− mice.
Mature C/EBP⑀ −/− granulocytic cells rapidly underwent apoptosis when recruited to the peritoneal cavity. The higher absolute number of granulocytic cells in the peripheral blood of C/EBP⑀ −/− mice, however, demonstrates that the net output of immature granulocytes is increased. This situation contrasts to myelodysplasia which is associated with intramedullary apoptosis of CD34-positive progenitor cells resulting in cytopenias of the peripheral blood. We hypothesize that C/EBP⑀ −/− granulocytic cells undergo apoptosis after activation by inflammatory stimuli such as thioglycollate in the peritoneal cavity or repeated exposure to gram-negative bacteria. Further studies in progress using subtractive libraries, representational difference analysis (RDA), and chip analysis using nucleotide arrays suggest that C/EBP⑀ expression is associated with the induction of expression of several antiapoptotic proteins and absence of expression of several chemokines.
